|
Match
|
Document |
Document Title |
|
|
8178083 |
Treatment of optic neuritis
The present invention provides a method for treating a patient having demyelinating optic neuritis (DON) comprising the sequential or simultaneous administration of a steroid compound and an...
|
|
|
8178518 |
Pharmaceutical composition
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
|
|
|
8168596 |
Use of cycloartane compounds for treating arthritis
A method of treating a disease associated with cartilage defect in a subject in need thereof by administering to the subject an effectively amount of a cycloartane compound of Formula (I).
|
|
|
8158612 |
Methods of treating disease states using antiangiogenic agents
Compositions and methods for treating mammalian diseases or conditions characterized by undesirable angiogenesis by administering an effective amount of a compound of the formulae: wherein Ra is...
|
|
|
8128905 |
Stabilized uncoated particles of reversed liquid crystalline phase materials
Uncoated particles of reversed cubic phase or reversed hexagonal phase material containing an active disposed within are provided. The uncoated particles have an ionic charge that is sufficient to...
|
|
|
8128906 |
Stabilized uncoated particles of reversed liquid crystalline phase materials
Uncoated particles of reversed cubic phase or reversed hexagonal phase material containing an active disposed within are provided. The uncoated particles have an ionic charge that is sufficient to...
|
|
|
8124596 |
Demethylpenclomedine analogs and their use as anti-cancer agents
This disclosure concerns novel demethylpenclomedine analogs. Also disclosed are pharmaceutical compositions and methods for using such compositions to treat hyperproliferative disorders. In one...
|
|
|
8124595 |
Graduated estrogen contraceptive
A multiphasic estrogenic/progestogenic contraceptive regimen that provides for the reduction or elimination of estrogen in the initial phase is disclosed. Also described is a contraceptive kit that...
|
|
|
8119605 |
Soluble tumor necrosis factor receptor treatment of medical disorders
The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNFα by administering a TNFα antagonist, such as r...
|
|
|
8119619 |
Pregnane steroids and their use in the treatment of CNS disorders
Steroid compounds possessing a hydrogen donor in 3beta position, either in the form of a hydroxy- or a sulfate group, function as efficient blockers of the 3alpha-hydroxy-pregnan-steroid action and...
|
|
|
8114860 |
GABA-steroid antagonists and their use for the treatment of CNS disorders
Compounds exhibiting 3alpha-hydroxy-5alpha/beta-steroid blocking action with no or only low antagonism against the gamma-aminobutyric acid (A) receptor (GABA-A), and compounds exhibiting partial...
|
|
|
8106036 |
Pharmaceutical compositions-4
The invention provides compositions comprising formula 1 steroids, e.g., 16α-bromo-3β-hydroxy-5α-androstan-17-one hemihydrate and one or more excipients, typically wherein the composition co...
|
|
|
8088753 |
Heparin conjugates and methods
Heparin conjugates and methods of making and use thereof are disclosed. An illustrative heparin conjugate includes a composition wherein a bile acid is bonded to heparin through the 3-carbon of the...
|
|
|
8088757 |
Betulinol derivatives as anti-cancer agents
The present invention relates to a method of treating cancer selected from the group of cancers consisting of prostate cancer, renal cancer, breast cancer, ovarian cancer, CNS cancer, melanoma,...
|
|
|
8084444 |
Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations
Dermatitis can be effectively treated with the combined administration of dehydroepiandrosterone (DHEA) and a glucocorticoid. Systemic, topical and prepackaged DHEA-glucocorticoid embodiments are...
|
|
|
8080538 |
Method for increasing absorption of steroid hormones
Compositions and methods are disclosed wherein one or more steroid hormones are combined in a mixture with a sulfur-containing compound. The sulfur-containing compound increases the absorption of...
|
|
|
8071547 |
Compositions of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer
The invention relates to novel compositions comprising alpha-fetoprotein (AFP) and methods for preventing, treating or inhibiting a malignant neoplasm expressing an alpha-fetoprotein receptor...
|
|
|
8071571 |
Orlistat compositions
A pharmaceutical combination or composition containing a lipase inhibitor, preferably orlistat, and a bile acid sequestrant is useful for treating obesity.
|
|
|
8071575 |
Methods and compounds for the targeted delivery of agents to bone for interaction therewith
Bone targeted compounds and methods are provided. Compounds can include a Bone Targeting Portion (RT), having an affinity for bone; a Bone Active Portion (RA) for interacting with and affecting...
|
|
|
8067400 |
Androgen treatment in females
A method of improving cumulative embryo score may comprise administering an androgen to a human female for at least about four consecutive months followed by harvesting and fertilizing oocytes and...
|
|
|
8063029 |
Pharmaceutical composition
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
|
|
|
8052669 |
Methods and devices for delivery of compositions to conduits
The present invention comprises systems, methods and devices for the delivery of visualizable or treatment compositions or therapeutic agents comprising device elements for diagnosis and/or...
|
|
|
8039012 |
Topical compositions for anti-aging and methods of using same
A pharmaceutical composition for treatment of skin aging including a pharmaceutically effective amount of estriol; a pharmaceutically effective amount of estradiol; a pharmaceutically effective...
|
|
|
8034798 |
Use of 3-methoxy-pregnenolone in the production of a medicament for treating neurodegenerative diseases
The invention relates to a novel use of derivatives of neurosteroids, particularly pregnenolone, for the treatment of acute or chronic lesions of the nervous system, especially certain...
|
|
|
8029845 |
Compositions of sugar-containing sterol solids dispersions
The invention relates to solids dispersions in the form of a solid solution containing a) at least about 0.1% by weight of sterols and/or stanols and/or esters thereof, and b) at least about 50% by...
|
|
|
8026228 |
Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
One aspect of the present invention relates to a method of hormone replacement in mammals, which method comprises the oral administration of an estrogenic component and a progestogenic component to...
|
|
|
8017648 |
Methods of use of cyclopamine analogs
The invention provides methods for treating various conditions using derivatives of cyclopamine having the following formula:
|
|
|
8008280 |
Betulinol derivatives as anti-HIV agents
The present invention relates to methods of treating HIV-1 infection in a subject. These methods involve administering to the subject with HIV-1 infection a therapeutically effective amount of a...
|
|
|
7994158 |
Method for inhibiting tumor growth with dehydrosulphurenic acid extracted from Antrodia cinnamomea
The present invention relates to a method for inhibiting tumor growth, in particular to the method using dehydrosulphurenic acid to inhibit the growth of leukemia cell or pancreatic cancer cell by...
|
|
|
7994213 |
Coating agent for drug releasing stent, preparation method thereof and drug releasing stent coated therewith
Disclosed are a coating agent for drug releasing stents, a method for preparing the same and a drug releasing stent coated therewith. The coating agent for drug releasing stents comprises...
|
|
|
7960367 |
Pregnane steroids and their use in the treatment of CNS disorders
Steroid compounds processing a hydrogen donor in 3beta position, either in the form of a hydroxy- or a sulfate group, function as efficient blockers of the 3alpha-hydroxy-pregnan-steroid action and...
|
|
|
7947667 |
Process and intermediates for the production of 7-substituted antiestrogens
A process for preparing an intermediate compound of formula (II) where X is as defined in the specification, R1 is haloalkyl, alkyl, alkenyl, cycloalkyl, carboxyalkyl, alkoxycarbonylalkyl, aryl or...
|
|
|
7943603 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
Novel methods for the medical treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded...
|
|
|
7935690 |
Pharmaceutical composition
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
|
|
|
7923440 |
Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
A method of treating or preventing an immune mediated disorder in a mammal, said method comprising the administration of a therapeutically effective amount of an estrogenic component to said...
|
|
|
7923032 |
Buoyant polymer particles for delivery of therapeutic agents to the central nervous system
The invention provides compositions and methods for treating a subject who has suffered from a central nervous system disorder. More particularly, the invention provides sustained polymeric drug...
|
|
|
7915237 |
Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl-xanthogenate and medicaments therefrom
The invention relates to pharmaceutical formulations containing exo/exo-tricyclo[5.2.1.02.6]-dec-9-yl-xanthogenate, drugs containing exo/exo-tricyclo[5.2.1.02.6]-dec-9-yl-xanthogenate as active...
|
|
|
7915225 |
Soluble tumor necrosis factor receptor treatment of medical disorders
The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNFα by administering a TNFα antagonist, such as r...
|
|
|
7910571 |
Cystic fibrosis treatment methods
The invention relates to the use of compounds to ameliorate or treat an condition such as a cystic fibrosis, neutropenia or other exemplified conditions. Exemplary compounds that can be used...
|
|
|
7888340 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Pregnane steroids and their use in the treatment of CNS disorders
Steroid compounds processing a hydrogen donor in 3beta position, either in the form of a hydroxy- or a sulfate group, function as efficient blockers of the 3alpha-hydroxy-pregnan-steroid action and...
|
|
|
7879830 |
Hormone replacement composition and method
Hormone compositions including bioidentical hormones dispersed in a lipid-based cream are provided in syringes for dispensation and self-administration by a user. The compositions, which are...
|
|
|
7858603 |
Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof
Compound of formula I where X=O or ═N—OH group, R represents a group chosen from A=hydrogen or together with B a carbon-carbon bond, B=hydrogen, hydroxy or together with A a carbon-carbon bond, C, ...
|
|
|
7858607 |
System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
The invention concerns a concentrated hormone pharmaceutical composition having from about 0.6 to about 80% of at least one hormone; from about 20 to about 90.4% of at least one solvent, and...
|
|
|
7851483 |
Medicaments comprising steroids and a novel anticholinergic
A pharmaceutical composition comprising: (a) a salt of formula 1 wherein: X− is an anion with a single negative charge; and(b) a steroid 2, processes for preparing such pharmaceutical c...
|
|
|
7851462 |
Methods and compositions for inhibiting tumor growth
The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid...
|
|
|
7846904 |
Compositions and methods for increasing telomerase activity
The present invention relates to methods for increasing telomerase activity in cells. Such compositions include pharmaceutical, including topical, and nutraceutical formulations. The method and...
|
|
|
7833994 |
Ethanol extraction of phytosterols from corn fiber
The present invention provides a process for extracting sterols from a high solids, thermochemically hydrolyzed corn fiber using ethanol as the extractant. The process includes obtaining a corn...
|
|
|
7829554 |
Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
Compositions, formulations, methods, and systems for treating regional fat deposits comprise contacting a targeted fat deposit with a composition comprising long acting beta-2 adrenergic receptor...
|
|
|
7815927 |
Terpolymers for controlled release of bioactive agents from implantable medical devices
Disclosed herein are implantable medical devices comprising controlled release terpolymers and at least one drug releasable from said terpolymers coating. The terpolymers of the present invention...
|
|
|
7811997 |
Composition containing total triterpenoid sapogenins extracted from bamboo, and the preparation method and use thereof
The invention relates to a composition containing total triterpenoid sapogenins extracted from bamboo, the preparation method and use thereof. These total triterpenoid sapogenins are extracted from...
|